LONDON (Reuters) - Over-the-counter drugmaker Unipharm is up for sale and has hired advisory firm Houlihan Lokey to explore a deal that could value it at around $500 million (310.83 million pounds), ...

Explore Unipharm AD stock price history with detailed daily historical prices, including open, high, low, and volume data. Review stock chart history to analyze past trends and find the highest ...

Background: Unipharm’s decision over Sanofi may change patent realm Judge Ofer Groskopf’s ruling could have a major impact on the drug and patent markets in Israel and even overseas.

ANTWERP, Belgium--(BUSINESS WIRE)--Regulatory News: Azelis (Brussels:AZE), a leading global innovation service provider in the specialty chemicals and food ingredients industry, announces that it has ...